 WESTLAKE VILLAGE, Calif., March 10, 2021 GLOBE NEWSWIRE -- MannKind Corporation Nasdaq: MNKD, a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 1:50 pm ET. Interested parties can access a link to the webcast from the Events Presentations section of the Companys website at The webcast replay will remain available for 14 days following the live presentation. 